PPT-Module 4: Mineral and Bone Disease in Chronic Kidney Disease

Andrew Narva MD FASN amp Amy Barton Pai PharmD MHI FASN FCCP FNKF Andrew Narva MD FASN No financial disclosuresconflicts of interest Amy Barton Pai PharmD MHI FASN FCCP FNKF. Liz Leen. Patient. Enez. Joaquin . 24 y/o Pima Indian . Diagnosed with T2DM at age 13. Has not been compliant with prescribed . . treatment. Progressive decompensation of . kidney function over past 7 years . Who gets this test done?. Why is it . needed?. How many different types?. What do the results mean?. Bone Mineral Density. HHHOLDORF. A bone mineral density test or BMD measures how much calcium and other types of minerals are in an area of your bone.. Epidemiology. CKD affects about 26 million people in the US. Approximately 19 million adults are in the early stages of the disease . On the rise do to increasing prevalence of diabetes and hypertension. Dr. T. A. L. . Dlamini. Specialist Physician and . Nephrologist. Talk overview . Kidney function. Assessing kidney function. Chronic kidney disease (CKD). Benefits of early detection . Conclusion and take home message . Shekhar. Sharma. Assistant Professor,. Department . of . Nephrology. AIIMS, . Rishikesh. . Staging. Chronic kidney disease (CKD) encompasses a spectrum of different pathophysiologic processes associated with abnormal kidney function and a progressive decline in glomerular filtration rate (GFR), present for >3 months.. . Renal Pharmacy Beginners Guide lecture 2 . P. rovide an introduction to the management of chronic kidney disease . Key aims of treatment in CKD. Risk factors for CKD . Frequently prescribed medication. Carrie L. Ernst, MD. Associate Professor of Psychiatry, . Icahn School of Medicine at Mount Sinai. Version of March 15, 2019. Learning Objectives. Describe symptoms and staging of kidney disease. Identify common psychiatric disorders in patients with chronic kidney disease and propose several management strategies. Chronic . c. are . Training . For . district . hospital . Nurses . in . Rwanda . 2013. Session 1: Defining chronic kidney disease. By the end of this Session, participants will be able to:. Screen for chronic kidney disease. !. Kidney . disease affects millions of people worldwide, including many children who may be at risk at an early age. . It . is therefore crucial that we encourage and facilitate education, early detection and a healthy life style in children, to fight the increase of preventable kidney diseases and to treat children with inborn and acquired disorders of the kidneys worldwide. . Structural . or functional abnormalities of the kidneys for . >. 3 months. . from early to late-stage disease, . Chronic Kidney Disease. as . manifested by either:. 1. Kidney . damage, with or without decreased GFR, as . In CKD and HD patients dysfunction of . immu. ne . sy. stem . a. lterations. . belonge. to . . involv. ing. . i. nnate. and . a. daptive. . i. mmunity. in T and B lymphocytes (. Reduced . T regulatory cells and memory cells and increased innate cells). . Stuart M. c. Adam, MD, FRCPC. General Internal Medicine. The Moncton Hospital. April 2022. Conflicts of Interest. Nothing to disclose. 2. Objectives. Describe an approach to the work-up of chronic kidney disease (CKD). Martha Cannon . BA VetMB DSAM(Fel) RCVS Specialist in Feline Medicine. Oxford Cat Clinic. Definitions. Acute kidney injury (AKI): . sudden damage to an otherwise healthy kidney. +/- loss of function, spectrum from mild to severe. 2017 . Annual Data Report. Volume 1: Chronic Kidney Disease. 2. vol. 1 Figure 4.1 Prevalence of common cardiovascular diseases in patients with or without CKD, 2015 . Data Source: Special analyses, Medicare 5% sample. Abbreviations: AF, atrial fibrillation; AMI, acute myocardial infarction; CAD, coronary artery disease; CKD, chronic kidney disease; CVA/TIA, cerebrovascular accident/transient ischemic attack; CVD, cardiovascular disease; HF, heart failure; PAD, peripheral arterial disease; SCA/VA, sudden cardiac arrest and ventricular arrhythmias; VHD, .